Gaining ligand selectivity in thyroid hormone receptors via entropy
- 8 December 2009
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 106 (49), 20717-20722
- https://doi.org/10.1073/pnas.0911024106
Abstract
Nuclear receptors are important targets for pharmaceuticals, but similarities between family members cause difficulties in obtaining highly selective compounds. Synthetic ligands that are selective for thyroid hormone (TH) receptor β (TRβ) vs. TRα reduce cholesterol and fat without effects on heart rate; thus, it is important to understand TRβ-selective binding. Binding of 3 selective ligands (GC-1, KB141, and GC-24) is characterized at the atomic level; preferential binding depends on a nonconserved residue (Asn-331β) in the TRβ ligand-binding cavity (LBC), and GC-24 gains extra selectivity from insertion of a bulky side group into an extension of the LBC that only opens up with this ligand. Here we report that the natural TH 3,5,3′-triodothyroacetic acid (Triac) exhibits a previously unrecognized mechanism of TRβ selectivity. TR x-ray structures reveal better fit of ligand with the TRα LBC. The TRβ LBC, however, expands relative to TRα in the presence of Triac (549 Å3 vs. 461 Å3), and molecular dynamics simulations reveal that water occupies the extra space. Increased solvation compensates for weaker interactions of ligand with TRβ and permits greater flexibility of the Triac carboxylate group in TRβ than in TRα. We propose that this effect results in lower entropic restraint and decreases free energy of interactions between Triac and TRβ, explaining subtype-selective binding. Similar effects could potentially be exploited in nuclear receptor drug design.This publication has 42 references indexed in Scilit:
- Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetesNature Reviews Drug Discovery, 2009
- Structural basis of GC-1 selectivity for thyroid hormone receptor isoformsBMC Structural Biology, 2008
- The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humansProceedings of the National Academy of Sciences of the United States of America, 2008
- Structural Rearrangements in the Thyroid Hormone Receptor Hinge Domain and Their Putative Role in the Receptor FunctionJournal of Molecular Biology, 2006
- The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugsProceedings of the National Academy of Sciences of the United States of America, 2006
- Scalable molecular dynamics with NAMDJournal of Computational Chemistry, 2005
- Thyroxine-Thyroid Hormone Receptor InteractionsOnline Journal of Public Health Informatics, 2004
- Molecular dynamics simulations of biomoleculesNature Structural & Molecular Biology, 2002
- Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonismNature Structural & Molecular Biology, 2002
- All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of ProteinsThe Journal of Physical Chemistry B, 1998